Deals in Depth: September 2009
Boston Scientific's lawsuit settlement with Cordis and concurrent IP license topped the alliance list at $716 million. Even without counting the two monster IPOs by Talecris ($550 million) and China's Sinopharm ($1.1 billion), total money raised in biopharma still increased in September by 26%. Device financing decreased by over $100 million to $266 million.
You may also be interested in...
If President Donald Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsburg, Affordable Care Act coverage could disappear. Two legal experts weigh in on this and other legal issues that could touch the medical device industry.
The Dutch start-up will use the funds to finalize product design for a neurostimulation platform targeting chronic migraines.
Signifier Medical Technologies is ramping up commercialization of its technology solutions for patients with snoring and sleep disordered breathing conditions.